BiondVax Pharmaceuticals Ltd. (BVXV)

NASDAQ: BVXV · Delayed Price · USD
1.26
-0.01 (-0.79%)
At close: May 25, 2022 4:00 PM
1.32
0.06 (4.76%)
After-hours:May 25, 2022 4:05 PM EDT

Income Statement (Annual)

Millions ILS. Fiscal year is Jan - Dec.
Year2021202020192018201720162015201420132012
Selling, General & Admin
24.5316.699.715.154.884.113.42.652.192.36
Research & Development
10.3451.4668.6571.9118.787.797.915.495.456.78
Other Operating Expenses
-0.04-75.4800000000
Operating Expenses
34.83-7.3378.3577.0723.6611.911.38.147.649.13
Operating Income
-34.837.33-78.35-77.07-23.66-11.9-11.3-8.14-7.64-9.13
Interest Expense / Income
10.8715.6330.8513.610.910.30.020.020.550.52
Other Expense / Income
-5.72-3.84-0-2.94-0.02-3.02-1.13-0.39-0.16-0.32
Pretax Income
-39.98-4.46-109.19-87.73-34.55-9.18-10.2-7.76-8.04-9.33
Net Income
-39.98-4.46-109.19-87.73-34.55-9.18-10.2-7.76-8.04-9.33
Net Income Common
-39.98-4.46-109.19-87.73-34.55-9.18-10.2-7.76-8.04-9.33
Shares Outstanding (Basic)
565443327261201135106544842
Shares Outstanding (Diluted)
565443327261201135106544842
Shares Change
27.37%35.70%24.95%30.04%48.80%28.03%94.38%13.22%15.45%-
EPS (Basic)
-2.80-0.40-13.20-13.60-6.80-2.80-4.00-5.60-6.80-8.80
EPS (Diluted)
-2.80-0.40-13.20-13.60-6.80-2.80-4.00-5.60-6.80-8.80
Free Cash Flow Per Share
-1.76-7.08-10.35-12.36-2.90-2.86-3.90-5.60-3.67-7.04
EBITDA
-26.713.61-76.7-73.87-23.2-8.26-9.55-7.07-6.78-8.08
EBIT
-29.1111.18-78.35-74.13-23.64-8.88-10.18-7.75-7.48-8.81
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).